6-160241585-T-C
Variant summary
Our verdict is Uncertain significance. Variant got 3 ACMG points: 3P and 0B. PM2PP3
The NM_003058.4(SLC22A2):āc.1390A>Gā(p.Asn464Asp) variant causes a missense, splice region change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000156 in 1,604,502 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 2/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_003058.4 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 3 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SLC22A2 | NM_003058.4 | c.1390A>G | p.Asn464Asp | missense_variant, splice_region_variant | 9/11 | ENST00000366953.8 | NP_003049.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SLC22A2 | ENST00000366953.8 | c.1390A>G | p.Asn464Asp | missense_variant, splice_region_variant | 9/11 | 1 | NM_003058.4 | ENSP00000355920.3 | ||
SLC22A2 | ENST00000486916.5 | n.429A>G | splice_region_variant, non_coding_transcript_exon_variant | 4/6 | 3 | |||||
SLC22A2 | ENST00000491092.1 | n.1287A>G | splice_region_variant, non_coding_transcript_exon_variant | 8/10 | 5 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152122Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000160 AC: 4AN: 250466Hom.: 0 AF XY: 0.0000148 AC XY: 2AN XY: 135338
GnomAD4 exome AF: 0.0000151 AC: 22AN: 1452262Hom.: 0 Cov.: 27 AF XY: 0.0000235 AC XY: 17AN XY: 723292
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152240Hom.: 0 Cov.: 31 AF XY: 0.0000403 AC XY: 3AN XY: 74440
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 05, 2022 | The c.1390A>G (p.N464D) alteration is located in exon 9 (coding exon 9) of the SLC22A2 gene. This alteration results from a A to G substitution at nucleotide position 1390, causing the asparagine (N) at amino acid position 464 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at